AI model could predict prostate cancer spread before surgery

NCT ID NCT07112599

Recruiting now Knowledge-focused Sponsor: Anhui Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is creating an artificial intelligence (AI) model that uses MRI scans and tissue samples to predict whether high-risk prostate cancer has spread to nearby lymph nodes. The goal is to help doctors make better treatment decisions without needing extra invasive tests. About 2,000 men with high-risk prostate cancer will participate to test how accurate the AI model is.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTIFICIAL INTELLIGENCE (AI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm in the lymph nodes prostate adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ARTIFICIAL INTELLIGENCE (AI) LYMPH NODE CANCER METASTATIC PROSTATE CANCER

Contacts and locations

Locations

Science and Technology Institute, Anhui Medical University
RECRUITING

Hefei, Anhui, 230022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.